Prevention and Treatment of SHIVAD8 Infection in Rhesus Macaques by a Potent D-peptide HIV Entry Inhibitor
Y. Nishimura, J. N. Francis, O. Donau, E. Jesteadt, R. Sadjadpour, A. R. Smith, M. S. Seaman, B. D. Welch, M. A. Martin, M. S. Kay
Abstract
Cholesterol-PIE12-trimer (CPT31) is a potent D-peptide HIV entry inhibitor that targets the highly conserved gp41 N-peptide pocket region. CPT31 exhibited strong inhibitory breadth against diverse panels of primary virus isolates. In a SHIV macaque model, CPT31 prevented infection from a single high-dose rectal challenge. In chronically infected animals, CPT31 monotherapy rapidly reduced viral load by ~2 logs before rebound occurred due to the emergence of drug resistance. In chronically infected animals with viremia initially controlled by combination antiretroviral therapy (cART), CPT31 monotherapy prevented viral rebound after discontinuation of cART. These data establish CPT31 as a promising new candidate for HIV prevention and treatment.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Potent antibody-dependent cellular cytotoxicity of a V2-specific antibody is not sufficient for protection of macaques against SIV challenge
M. W. Grunst, H. M. Gil, … D. T. Evans·bioRxiv·Nov 14, 2023
- Piperidine CD4-mimetic compounds expose vulnerable Env epitopes sensitizing HIV-1-infected cells to ADCC
S. Ding, W. D. Tolbert, … A. Finzi·bioRxiv·Mar 23, 2023
- CD8+ cells and small viral reservoirs facilitate post-ART control of SIV in Mauritian cynomolgus macaques
O. E. Harwood, L. M. Matschke, … S. L. O'Connor·bioRxiv·Mar 1, 2023
- SIV clearance from neonatal macaques following transient CCR5 depletion
J. D. Deere, D. Merriam, … D. J. Hartigan-O'Connor·bioRxiv·May 1, 2023
- Ultra-long-acting refillable nanofluidic implant confers full protection against SHIV infection in non-human primates
F. P. Pons-Faudoa, N. Di Trani, … A. Grattoni·bioRxiv·Dec 15, 2022
- A novel HIV triple broadly neutralizing antibody (bNAb) combination-based passive immunization of infant rhesus macaques achieves durable protective plasma neutralization levels and mediates anti-viral effector functions.
S. Dankwa, C. Kosman, … R. Goswami·PLOS ONEPeer-reviewed·Nov 11, 2024